Bayesian Adaptive trial design: Making planned, well-defined changes in key clinical trial design parameters, during trial execution based on data from that trial, to achieve goals of validity, scientific efficiency, and safety.
June 4, 2020
Bayesian Adaptive trial design: Making planned, well-defined changes in key clinical trial design parameters, during trial execution based on data from that trial, to achieve goals of validity, scientific efficiency, and safety.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
